Le Registre des lobbyistes
Becton Dickinson Canada Inc
| Objets | Détails | Catégories |
|---|---|---|
|
Développement économique, Affaires étrangères, Marchés publics, Santé, Industrie, Relations internationales, Commerce international, Sécurité nationale/sécurité, Sciences et technologies
|
Canadian-United States-Mexico Agreement (CUSMA) with respect to provisions relating to medical devices and technologies
|
Règlement, Politique ou Programme, Proposition législative, Projet de loi ou résolution
|
|
Budget, Relations fédérales-provinciales, Marchés publics, Santé, Industrie
|
Discuss policies around healthcare system resiliency, infection prevention, medication errors, women's health, and health equity
|
Politique ou Programme, Règlement
|
|
Développement économique, Relations fédérales-provinciales, Marchés publics, Santé, Industrie, Sciences et technologies, Impôts et finances
|
Federal budget with respect to medical technology and device innovation and adoption, support and delivery of new models of care, equitable healthcare access, women’s health, and investments in long-term care and home care
|
Proposition législative, Projet de loi ou résolution
|
|
Développement économique, Marchés publics, Santé, Industrie, Sciences et technologies
|
Federal guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry, and economic development and promotion for the life sciences sector
|
Politique ou Programme
|
|
Développement économique, Santé, Industrie, Recherche et développement, Sciences et technologies
|
Federal life sciences strategy, focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry and accelerating innovation to improve health and economic outcomes.
|
Politique ou Programme
|
|
Développement économique, Marchés publics, Santé, Industrie, Commerce international, Recherche et développement, Sciences et technologies
|
Federal life sciences strategy with respect to global value chain and supply chain management and investment towards medical technology manufacturing and export.
|
Règlement, Proposition législative, Projet de loi ou résolution, Politique ou Programme
|
|
Relations fédérales-provinciales, Santé, Industrie
|
Federal life sciences strategy with respect to patient safety, managing high-risk drugs, medication errors, healthcare worker safety, infection and disease prevention, antimicrobial resistance, and diagnostic testing.
|
Politique ou Programme
|
|
Santé, Industrie, Sciences et technologies
|
Regulations under the Food and Drugs Act, including the Medical Devices Regulation, with respect to the approval of medical technologies
|
Règlement
|